In BREAKWATER, EC plus FOLFIRI achieved a 64.4% response rate and showed a trend toward improved overall survival in patients ...
Delayed musculoskeletal symptoms after breast radiotherapy can reflect osteoradionecrosis rather than recurrence, thus ...
Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...
Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating ...
With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...
This case describes a woman in her mid-40s with recurrent colorectal cancer who developed severe dermatologic toxicity during ...
Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 monthsNotable ...
In October 2025, Case Comprehensive Cancer Center announced a clinical trial is to see if shorter Photodynamic Therapy (PDT) ...
Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...
The Palm Beaches are redefining relaxation with a wave of fresh spa experiences and innovative wellness offerings. From cutting-edge treatments at newly renovated resorts to immersive mind-body ...
Vitamin B3, or niacin, is essential in small amounts for normal body function. The skin, nerves, and digestive system all require vitamin B3. Research has | Cancer ...
Researchers found that sunburn disables a natural skin defense, allowing inflammation to trigger dangerous changes in cells. Understanding this process could help stop skin cancer before it starts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback